A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Unlike other types of dementia, such as Alzheimer’s Disease, there are no treatments; but a new drug — sodium selenate — was shown to be safe and well tolerated in people living with bvFTD, as ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

Now, for the first time, a new group of drugs called monoclonal antibodies have been shown to slow down the decline in thinking and memory in Alzheimer’s patients, the most common form of dementia.

We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another ...

Lewy Body Dementia is progressive, and causes uncontrollable tremors, problems with memory, attention, and sleep.

Tau proteins help to stabilise the internal skeleton of nerve cells (neurons) in the brain. But in Alzheimer’s disease, these ...

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.